GemVax & KAEL Revenue

Biotechnology Research • 분당구 운중로 117 (117, Unjung-ro, Korea, Republic of • 21-50 Employees

GemVax & KAEL revenue & valuation

Annual revenue	$3,165,535
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$10,200,000
Total funding	No funding

Key Contacts at GemVax & KAEL

Hyun Jin Cho

R&D Center, Director

승재 변

이사 Director

Moonhwan Do

투자자 전담Ir 책임자, Director

Company overview

Headquarters	분당구 운중로 117 (117, Unjung-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea), 성남시, 경기도 13461, KR
Phone number	+82429316287
Website	gemvax.com
NAICS	541714
Keywords	Drug Development, Cancer, BPH, PSP, Biopharmaceutical, Alzheimer'S Disease, Peptide Drug, Htert
Founded	1998
Employees	21-50
Socials

GemVax & KAEL Email Formats

GemVax & KAEL uses 2 email formats. The most common is {first name} (e.g., john@gemvax.com), used 50% of the time.

Format	Example	Percentage
{first name}	john@gemvax.com	50%
{first name}.{last name}	john.doe@gemvax.com	50%

About GemVax & KAEL

Since 2008, GemVax & KAEL has operated as a cutting-edge research and development company developing proprietary peptide drug, GV1001, for treatment against various cancers and neurodegenerative disease including Alzheimer's disease and Progressive Supranuclear palsy. The fundamental driving purpose of our innovative pharmaceutical research is to facilitate significant improvements to human life through the introduction of advanced medical technology and innovation rooted in advanced scientific measures. At GemVax, we take pride in our proactive approach to medical research, and our progressive peptide-drug focused advancements have played a crucial role in the incessant global battle against incurable disease.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Manager

Entry

Director

Employees by Department

GemVax & KAEL has 7 employees across 4 departments.

Departments

Number of employees

Funding Data

GemVax & KAEL has never raised funding before.

GemVax & KAEL Tech Stack

Discover the technologies and tools that power GemVax & KAEL's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Modernizr

JavaScript libraries

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

OpenSSL

Web server extensions

Gnuboard

CMS

PHP

Programming languages

Font Awesome

Font scripts

UNIX

Operating systems

MySQL

Databases

jQuery Migrate

JavaScript libraries

Frequently asked questions

GemVax & KAEL is located in 분당구 운중로 117 (117, Unjung-ro, KR.

You can reach GemVax & KAEL at +82429316287.

GemVax & KAEL generates an estimated annual revenue of $3,165,535. This revenue figure reflects the company's market position and business performance in its industry.

GemVax & KAEL has an estimated valuation of $10,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

GemVax & KAEL was founded in 1998, making it 28 years old. The company has established itself as a significant player in its industry over this time.

GemVax & KAEL has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at GemVax & KAEL

Hyun Jin Cho

R&D Center, Director

승재 변

이사 Director

Moonhwan Do

투자자 전담Ir 책임자, Director

4.8

40,000 users